Determination of the effects of irisin hormone in SKMEL-30 cells
Author:
Turker Nebiye1ORCID, Bakar Elvan2ORCID
Affiliation:
1. Technology Research Development Application and Research Center (TÜTAGEM), Trakya University, Edirne, Turkey 2. Faculty of Farmacy, Department of Basic Pharmaceutical Sciences, Trakya University, Edirne, Turkey
Abstract
Melanocytes, the skin's pigment-producing cells, are the source of the skin
cancer known as melanoma. Numerous variables, including as immune system
interactions, tumor microenvironment, and genetic alterations, have an
impact on the development and behavior of melanoma. The purpose of this
study was to ascertain the impact of irisin on melanoma cells. The molecular
effects of irisin SKMEL-30 on human melanoma cancer cells were examined for
this aim. By using MTT technique, the effects of irisin on cell growth were
examined. Real-time polymerase chain reaction was used to examine changes in
gene expression level. The concentrations of sialic acid were measured using
spectrophotometry. In the investigation, the irisin IC50 value for a 24-hour
application was determined to be 30 nM. In comparison to the control group,
sialic acid levels in the irisin-treated group of SKMEL-30 cells were
significantly lower. In the qRT-PCR investigation, ST8SIA-2, one of the
glycosyltransferase genes, increased 12.591-fold in the application group
whereas cas8, one of the apoptotic genes, increased 82.481-fold. In
conclusion, flow cytometry analyses proved that administration of 30 nM
irisin to SKMEL-30 cells influences cell proliferation but does not cause
apoptosis. It was shown that sialic acid substitution reduced the
proliferative and metastatic potential of SKMEL- 30 cells.
Publisher
National Library of Serbia
Reference23 articles.
1. AHMED, B., M.I., QADIR, S., GHAFOOR (2020): Malignant Melanoma: Skin Cancer-Diagnosis, Prevention, and Treatment. Critical reviews in eukaryotic gene expression, 30(4): 291-297. 2. AYDIN, S., T., KULOGLU, M.R., OZERCAN, S., ALBAYRAK, S., AYDIN, U., BAKAL, M., YILMAZ, M., KALAYCI, M., YARDIM, M., SARAC, A., KAZEZ, H., KOCDOR, B., KANAT, I.H., OZERCAN, M., GONEN, M., BILGEN, F., BALGETIR (2016): Irisin immunohistochemistry in gastrointestinal system cancers. Biotechnic & histochemistry: official publication of the Biological Stain Commission, 91(4): 242-250. 3. BOBOS, M. (2021): Histopathologic classification and prognostic factors of melanoma: a 2021 update. Italian journal of dermatology and venereology, 156(3): 300-321. 4. CASSETTA, L., S., FRAGKOGIANNI, A.H., SIMS, A., SWIERCZAK, L.M., FORRESTER, H., ZHANG, D.Y.H., SOONG, T., COTECHINI, P., ANUR, E.Y., LIN, A., FIDANZA, M., LOPEZ-YRIGOYEN, M.R., MILLAR, A., URMAN, Z., AI, P.T., SPELLMAN, E.S., HWANG, J.M., DIXON, L., WIECHMANN, L.M., COUSSENS, … J.W., POLLARD (2019): Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer cell, 35(4): 588-602.e10. 5. DZWIERZYNSKI, W.W. (2021): Melanoma Risk Factors and Prevention. Clinics in plastic surgery, 48(4): 543-550.
|
|